| Bioactivity | LSD1/HDAC-IN-1 (compound 2) is a potent inhibitor of HDAC and LSD1, with IC50s of 0.125 nM, 0.373 nM, 0.0118 nM, 0.103 nM, and 0.571 μM for HDAC1, HDAC2, HDAC6, HDAC8 and LSD1, respectively. LSD1/HDAC-IN-1 plays an important role in cancer research[1]. |
| CAS | 3056145-98-0 |
| Formula | C18H18N2O4S |
| Molar Mass | 358.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Po-Yu Chou, et al. Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids. J Med Chem. 2024 Oct 10;67(19):17207-17225. |
LSD1/HDAC-IN-1
CAS: 3056145-98-0 F: C18H18N2O4S W: 358.41
LSD1/HDAC-IN-1 (compound 2) is a potent inhibitor of HDAC and LSD1, with IC50s of 0.125 nM, 0.373 nM, 0.0118 nM, 0.103 n
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.